NCT07045168Not yet recruiting
Risk-adapted Therapeutic Strategy in +1q NDMM
Risk-adapted Therapeutic Strategy in +1q NDMM： a Prospective, Multicenter Study
Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This real-world, multicenter prospective clinical study is designed to apply our internationally developed prognostic scoring system to guide individualized therapy in +1q newly diagnosed multiple myeloma (NDMM), using minimal residual disease (MRD) status as the primary endpoint.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 18 Jun 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 15 Sept 2027
- Lead sponsor
- FengYan Jin
- Diseases
- Multiple myeloma, Childhood cancers
- NCT number
- NCT07045168
What you commit to
- Study type: Observational
- Planned participants: 200
- From 15 Sept 2025 to the primary completion date, 15 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of hematologic or solid tumors treated with chemo/radiotherapy within 5 years.
Other illness
- Active infections requiring systemic treatment.
- Unstable angina, NYHA class III-IV heart failure, or uncontrolled arrhythmias.
- Current malignancies requiring therapy.
Other
- Refusal to participate.
Who the study is looking for
- Age \>=18, or \>=65 and fit according to IMWG-FI.
- Newly diagnosed NDMM by 2014 IMWG criteria.
- Adequate organ function for systemic therapy.
- Signed informed consent.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Hospital of Jilin University Coordinator of this site? Confirm its status | Changchun | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.